分子生物学の酵素、キット、試薬市場

出版：MarketsandMarkets

分子生物学の酵素、キット、試薬市場：製品別（キット、試薬、酵素）、用途（PCR、シーケンス処理、合成生物学）、エンドユーザ（研究所、製薬およびバイオ技術企業、病院）、地域別の2026年までの世界市場予測

Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region – Global Forecast to 2026

–

–

MarketsandMarkets出版の当調査レポートは世界の分子生物学における酵素、キット、試薬市場を詳細に調査・分析し、2026年までの市場予測も行っています。

The global molecular biology enzymes and kits & reagents market is projected to USD 29.7 billion by 2026 from USD 15.3 billion in 2021, at a CAGR of 14.2% during the forecast period. The rising number of genome projects coupled with reducing genetic analysis costs helps advance research in various domains, such as disease treatment, personalized medicine, and microbial genetics. These processes require the use of various molecular biology enzymes and reagents and are thus expected to drive the molecular biology enzymes and kits & reagents market. However, factors such as limited reimbursements for genetic testing is likely to hinder the growth of this market.

“The kits & reagents segment accounted for the highest growth rate in the molecular biology enzymes and kits & reagents market, by product, during the forecast period”
The molecular biology enzymes and kits & reagents market is segmented into enzymes and kits & reagents. The kits & reagents segment accounted for the largest share of 85.9% of the global molecular biology enzymes and kits & reagents market in 2020. The large share of this segment can primarily be attributed to the repeat purchase of these single-use products. This segment is also expected to grow at the highest rate owing to its wide applications by pharmaceutical & biotechnology companies.

“Polymerase chain reaction (PCR) segment accounted for the largest share”
Based on applications, the global molecular biology enzymes and kits & reagents market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection).
The polymerase chain reaction (PCR) segment accounted for the largest share of the molecular biology enzymes and kits & reagents market in 2020, mainly due to the low cost of PCR equipment, the extensive use of PCR equipment by a majority of end users, and the increasing use of PCR for molecular diagnostic assays in hospitals and clinics.

“Asia Pacific: The fastest-growing region in the molecular biology enzymes and kits & reagents market”
The molecular biology enzymes and kits & reagents market is segmented into North America, Europe, Asia Pacific, RoW. The molecular biology enzymes and kits & reagents market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in the APAC market is driven by increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and the growing outsourcing of clinical research activities to Asian countries.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level – 25%, D-level – 20%, and Others – 55%
• By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%
Lists of Companies Profiled in the Report:
• Thermo Fisher (US)
• Merck (Germany)
• Illumina (US)
• QIAGEN (Netherlands)
• New England Biolabs (US)
• Promega (US)
• Agilent (US)
• Roche (Switzerland)
• Takara Bio (Japan)
• Bio Basic (Canada)
• Jena Bioscience (Germany)
• Molecular Biology Resources (US)
• Bio-Rad Laboratories Inc. (US)
• Zymo Research Corporation (US)
• Integrated DNA Technologies Inc. (US)
• LGC Biosearch Technologies (UK)
• NZYTech (Portugal) Lucigen Corporation (US)
• MoBiTec GmbH (Germany)
• Genekam Biotechnology (Germany)
• Aldevron (US) Randox (Northern Ireland)
• ADS Biotec Inc. (US)
• Hangzhou Matridx Biotechnology Co. Ltd. (China)
• Goldsite Diagnostics Inc. (China)

Research Coverage:
This report provides a detailed picture of the molecular biology enzymes and kits & reagents market. It aims at estimating the size and future growth potential of the market across different segments such as the service end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall molecular biology enzymes and kits & reagents market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.”

目次

“1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS & EXCLUSIONS 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 31
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS 31
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH APPROACH 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 33
2.1.2 PRIMARY DATA 34
FIGURE 2 BREAKDOWN OF PRIMARIES: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 35
2.2 MARKET DATA ESTIMATION & TRIANGULATION 36
FIGURE 3 DATA TRIANGULATION METHODOLOGY 36
2.3 MARKET ESTIMATION METHODOLOGY 37
FIGURE 4 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS 37
FIGURE 5 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SIZE
(USD BILLION): FINAL MARKET SIZE 38
2.4 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 38
FIGURE 6 GROWTH RATE ASSUMPTION BASED ON MARKET DYNAMICS 39
FIGURE 7 FINAL CAGR PROJECTIONS (2021−2026) 39
2.5 INSIGHTS FROM PRIMARIES 40
FIGURE 8 MARKET VALIDATION FROM PRIMARY EXPERTS 40
2.6 RESEARCH ASSUMPTIONS 40
2.7 RISK ASSESSMENT 41
TABLE 1 RISK ASSESSMENT 41
3 EXECUTIVE SUMMARY 42
FIGURE 9 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SHARE,
BY PRODUCT, 2020 42
FIGURE 10 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SHARE,
BY APPLICATION, 2020 43
FIGURE 11 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2021 VS. 2026 (USD MILLION) 44
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 45
4 PREMIUM INSIGHTS 46
4.1 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET OVERVIEW 46
FIGURE 13 INCREASING R&D INVESTMENTS IN THE LIFE SCIENCE INDUSTRY TO DRIVE MARKET GROWTH 46
4.2 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 47
FIGURE 14 KITS & REAGENTS TO COMMAND THE LARGEST SHARE OF THE NORTH AMERICAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 47
4.3 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION 47
FIGURE 15 PCR APPLICATIONS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 47
4.4 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 16 MARKETS IN THE ASIA PACIFIC REGION TO REGISTER HIGHER GROWTH RATES BETWEEN 2021 & 2026 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 17 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 49
5.2.1 DRIVERS 50
5.2.1.1 Growing number of genome projects 50
5.2.1.2 Technological advancements in the life science industry 51
5.2.1.3 Rising incidence of genetic disorders 51
5.2.2 RESTRAINTS 52
5.2.2.1 Limited reimbursements for genetic testing 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Increased use of personalized medicine 52
TABLE 2 GOVERNMENT FUNDING FOR PERSONALIZED MEDICINE 53
5.2.3.2 R&D investments offer significant opportunities for the market 53
5.3 COVID-19 IMPACT ANALYSIS 53
FIGURE 18 COUNTRY-WISE DAILY TESTS FOR COVID-19 54
5.4 TECHNOLOGY ANALYSIS 55
TABLE 3 TRADITIONAL BIOLOGY VS. MOLECULAR BIOLOGY 55
5.5 VALUE CHAIN ANALYSIS 55
FIGURE 19 VALUE CHAIN ANALYSIS OF THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 56
5.6 SUPPLY CHAIN ANALYSIS 56
FIGURE 20 SUPPLY CHAIN OF THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 57
5.7 PORTERS FIVE FORCES ANALYSIS 58
5.7.1 THREAT FROM NEW ENTRANTS 58
5.7.2 THREAT FROM SUBSTITUTES 59
5.7.3 BARGAINING POWER OF SUPPLIERS 59
5.7.4 BARGAINING POWER OF BUYERS 59
5.7.5 INTENSITY OF COMPETITION RIVALRY 59
5.8 REGULATORY LANDSCAPE 60
TABLE 4 REGULATORY LANDSCAPE FOR THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 60
5.9 PRICING ANALYSIS 62
TABLE 5 PRICING ANALYSIS FOR MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS 62
5.10 PATENT ANALYSIS 63
FIGURE 21 PATENT ANALYSIS FOR THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET (2010–2020) 63
6 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT 64
6.1 INTRODUCTION 65
TABLE 6 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 65
6.2 KITS & REAGENTS 65
6.2.1 WIDE APPLICATIONS OF KITS & REAGENTS AND THEIR EXTENSIVE USAGE IN VARIOUS APPLIED INDUSTRIES TO DRIVE MARKET GROWTH 65
TABLE 7 MOLECULAR BIOLOGY KITS & REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 66
TABLE 8 NORTH AMERICA: MOLECULAR BIOLOGY KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 66
TABLE 9 EUROPE: MOLECULAR BIOLOGY KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 66
TABLE 10 APAC: MOLECULAR BIOLOGY KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 67
6.3 ENZYMES 67
TABLE 11 MOLECULAR BIOLOGY ENZYMES MARKET, BY REGION,
2019–2026 (USD MILLION) 67
TABLE 12 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 68
TABLE 13 EUROPE: MOLECULAR BIOLOGY ENZYMES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 68
TABLE 14 APAC: MOLECULAR BIOLOGY ENZYMES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 68
6.3.1 POLYMERASES 69
6.3.1.1 Growing use of polymerases in PCR to drive segmental growth 69
TABLE 15 MOLECULAR BIOLOGY ENZYMES MARKET FOR POLYMERASES, BY REGION, 2019–2026 (USD MILLION) 69
6.3.2 LIGASES 69
6.3.2.1 Growing demand for ligases in cloning experiments to boost growth in this market segment 69
TABLE 16 MOLECULAR BIOLOGY ENZYMES MARKET FOR LIGASES, BY REGION,
2019–2026 (USD MILLION) 70
6.3.3 RESTRICTION ENDONUCLEASES 70
6.3.3.1 Wide applications of restriction endonucleases in gene mapping and genotyping—a key factor driving market growth 70
TABLE 17 MOLECULAR BIOLOGY ENZYMES MARKET FOR RESTRICTION ENDONUCLEASES, BY REGION, 2019–2026 (USD MILLION) 70
6.3.4 REVERSE TRANSCRIPTASES 71
6.3.4.1 Increasing demand for RT-PCR diagnostic tests to fuel the adoption of reverse transcriptases 71
TABLE 18 MOLECULAR BIOLOGY ENZYMES MARKET FOR REVERSE TRANSCRIPTASES, BY REGION, 2019–2026 (USD MILLION) 71
6.3.5 OTHER ENZYMES 71
TABLE 19 MOLECULAR BIOLOGY ENZYMES MARKET FOR OTHER ENZYMES, BY REGION, 2019–2026 (USD MILLION) 72
7 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION 73
7.1 INTRODUCTION 74
TABLE 20 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 74
7.2 POLYMERASE CHAIN REACTION 75
7.2.1 TECHNOLOGICAL ADVANCEMENTS IN PCR TO DRIVE GROWTH IN THIS MARKET SEGMENT 75
TABLE 21 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PCR APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 75
TABLE 22 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PCR APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 76
TABLE 23 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PCR APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 76
TABLE 24 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PCR APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 76
7.3 SEQUENCING 77
7.3.1 DECREASING COST OF SEQUENCING, COUPLED WITH RISING DEMAND FOR PERSONALIZED MEDICINE, TO DRIVE MARKET GROWTH 77
TABLE 25 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SEQUENCING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 77
TABLE 26 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 78
TABLE 27 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 78
TABLE 28 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 78

7.4 CLONING 79
7.4.1 RISING APPLICATIONS OF CLONING KITS TO DRIVE GROWTH IN THIS MARKET SEGMENT 79
TABLE 29 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR CLONING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 79
TABLE 30 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR CLONING APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 79
TABLE 31 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR CLONING APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 80
TABLE 32 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR CLONING APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 80
7.5 EPIGENETICS 80
7.5.1 HIGH PREVALENCE OF CANCER IS LIKELY TO BOOST MARKET GROWTH 80
TABLE 33 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR EPIGENETICS APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 81
TABLE 34 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR EPIGENETICS APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 81
TABLE 35 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR EPIGENETICS APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 36 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR EPIGENETICS APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 82
7.6 SYNTHETIC BIOLOGY 82
7.6.1 DECREASING MARKET PRICES FOR GENE SYNTHESIS TO DRIVE MARKET GROWTH 82
TABLE 37 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SYNTHETIC BIOLOGY APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 83
TABLE 38 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SYNTHETIC BIOLOGY APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 83
TABLE 39 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SYNTHETIC BIOLOGY APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 84
TABLE 40 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SYNTHETIC BIOLOGY APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 84
7.7 RESTRICTION DIGESTION 84
7.7.1 GROWTH IN GENE-BASED RESEARCH ACTIVITIES HAS BOOSTED SEGMENTAL GROWTH 84
TABLE 41 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR RESTRICTION DIGESTION APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 85
TABLE 42 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR RESTRICTION DIGESTION APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 85
TABLE 43 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR RESTRICTION DIGESTION APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 85
TABLE 44 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR RESTRICTION DIGESTION APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 86
7.8 OTHER APPLICATIONS 86
TABLE 45 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 46 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 87
TABLE 47 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 87
8 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER 88
8.1 INTRODUCTION 89
TABLE 48 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 89
8.2 ACADEMIC & RESEARCH INSTITUTES 89
8.2.1 INCREASING RESEARCH ACTIVITIES BACKED BY FUNDING FROM GOVERNMENT AND PRIVATE ORGANIZATIONS TO DRIVE MARKET GROWTH 89
TABLE 49 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,
2019–2026 (USD MILLION) 90
TABLE 50 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION) 90
TABLE 51 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION) 91
TABLE 52 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION) 91
8.3 HOSPITALS & DIAGNOSTIC CENTERS 91
8.3.1 INCREASING LAUNCHES OF PRODUCTS USED IN HOSPITALS & DIAGNOSTIC CENTERS TO DRIVE MARKET GROWTH 91
TABLE 53 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION,
2019–2026 (USD MILLION) 92
TABLE 54 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 92
TABLE 55 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 92
TABLE 56 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 93

8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 93
8.4.1 INCREASING DRUG RESEARCH AND R&D EXPENDITURE TO DRIVE GROWTH IN THIS END-USER SEGMENT 93
TABLE 57 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2019–2026 (USD MILLION) 93
TABLE 58 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 59 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 60 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2019–2026 (USD MILLION) 94
8.5 OTHER END USERS 95
TABLE 61 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION) 95
TABLE 62 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 95
TABLE 63 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 96
TABLE 64 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 96
9 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY REGION 97
9.1 INTRODUCTION 98
FIGURE 22 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SNAPSHOT 98
TABLE 65 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY REGION, 2019–2026 (USD MILLION) 98
TABLE 66 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS (HOME BREW TEST) MARKET, BY REGION, 2019–2026 (USD MILLION) 99
9.2 NORTH AMERICA 100
FIGURE 23 NORTH AMERICAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SNAPSHOT 100
TABLE 67 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 68 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 101
TABLE 69 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE,
2019–2026 (USD MILLION) 101
TABLE 70 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 102
TABLE 71 NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 102
9.2.1 US 102
9.2.1.1 Increasing research in genomics to propel market growth in the US 102
TABLE 72 US: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 103
TABLE 73 US: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 103
TABLE 74 US: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 104
9.2.2 CANADA 104
9.2.2.1 Growing investments and funding in research projects to drive the growth of the Canadian market 104
TABLE 75 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 105
TABLE 76 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 105
TABLE 77 CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 105
9.3 EUROPE 106
TABLE 78 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 79 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 106
TABLE 80 EUROPE: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 81 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 107
TABLE 82 EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 107
9.3.1 GERMANY 108
9.3.1.1 Increasing pharmaceutical R&D in Germany to drive market growth in the coming years 108
TABLE 83 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 108
TABLE 84 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 109
TABLE 85 GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 109
9.3.2 UK 109
9.3.2.1 The 100,000 Genomes Project drives the demand for molecular biology enzymes and kits & reagents in the UK 109
TABLE 86 UK: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 110
TABLE 87 UK: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 110
TABLE 88 UK: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 110
9.3.3 FRANCE 111
9.3.3.1 Investments in the Genomic Medicine 2025 plan to drive market growth 111
TABLE 89 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 112
TABLE 90 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 112
TABLE 91 FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 112
9.3.4 ITALY 113
9.3.4.1 Large biotechnology and pharmaceutical industry in Italy to drive market growth 113
TABLE 92 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 113
TABLE 93 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 113
TABLE 94 ITALY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 114
9.3.5 ROE 114
TABLE 95 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 114
TABLE 96 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 115
TABLE 97 ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 115
9.4 ASIA PACIFIC 116
FIGURE 24 APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SNAPSHOT 116
TABLE 98 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 99 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 117
TABLE 100 APAC: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 101 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 118
TABLE 102 APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 118
9.4.1 JAPAN 118
9.4.1.1 Growing focus on cancer research and treatment is expected to augment market growth in Japan 118
TABLE 103 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 119
TABLE 104 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 119
TABLE 105 JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 119
9.4.2 CHINA 120
9.4.2.1 Increasing R&D investments and outsourcing of clinical research activities to China to drive market growth 120
TABLE 106 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 120
TABLE 107 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 121
TABLE 108 CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 121
9.4.3 INDIA 121
9.4.3.1 Development of bio-clusters and biotech parks to propel the biotechnology industry in India 121
TABLE 109 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 122
TABLE 110 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 123
TABLE 111 INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 123
9.4.4 ROAPAC 123
TABLE 112 ROAPAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 124
TABLE 113 ROAPAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 124
TABLE 114 ROAPAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 125
9.5 REST OF THE WORLD (ROW) 125
TABLE 115 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY REGION, 2019–2026 (USD MILLION) 125
TABLE 116 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 125
TABLE 117 ROW: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 118 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 126
TABLE 119 ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 126
9.5.1 LATIN AMERICA 127
9.5.1.1 Investments in research backed by workshops and conferences to drive market growth 127
TABLE 120 LIST OF COURSES AND WORKSHOPS HELD IN LATIN AMERICA BY THE INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (ICGEB) 127
TABLE 121 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 127
TABLE 122 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 128
TABLE 123 LATIN AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 128
9.5.2 MIDDLE EAST & AFRICA 128
9.5.2.1 Growing prevalence of cancer and increasing funding for molecular diagnostics to drive market growth 128
TABLE 124 MEA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 129
TABLE 125 MEA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 129
TABLE 126 MEA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 130
10 COMPETITIVE LANDSCAPE 131
10.1 OVERVIEW 131
10.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 131
10.3 MARKET SHARE ANALYSIS 132
FIGURE 26 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET RANK,
BY KEY PLAYER, 2020 132
TABLE 127 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: DEGREE OF COMPETITION 133
10.4 COMPETITIVE LEADERSHIP MAPPING 134
10.4.1 STARS 134
10.4.2 EMERGING LEADERS 134
10.4.3 PERVASIVE PLAYERS 135
10.4.4 PARTICIPANTS 135
FIGURE 27 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: COMPANY EVALUATION QUADRANT (2020) 135
10.5 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: SME EVALUATION MATRIX, 2020 136
10.5.1 PROGRESSIVE COMPANIES 136
10.5.2 STARTING BLOCKS 136
10.5.3 RESPONSIVE COMPANIES 136
10.5.4 DYNAMIC COMPANIES 136
FIGURE 28 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: STARTUP/SME EVALUATION MATRIX, 2020 137
10.6 COMPANY PRODUCT FOOTPRINT 138
TABLE 128 PRODUCT PORTFOLIO ANALYSIS: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 138
10.7 COMPANY GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET 139
TABLE 129 GEOGRAPHIC REVENUE MIX: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET (2020) 139
10.8 COMPETITIVE SCENARIO 140
10.8.1 PRODUCT LAUNCHES 140
TABLE 130 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: PRODUCT LAUNCHES, FEBRUARY 2020–FEBRUARY 2021 140
10.8.2 DEALS 141
TABLE 131 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: DEALS, JANUARY 2018–FEBRUARY 2021 141
10.8.3 OTHER DEVELOPMENTS 142
TABLE 132 MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: OTHER DEVELOPMENTS, JULY 2018–DECEMBER 2020 142

11 COMPANY PROFILES 143
11.1 MAJOR PLAYERS 143
(Business Overview, Products/Solutions Offered, Recent Developments, Right to Win)*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 143
TABLE 133 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 143
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020) 144
11.1.2 MERCK KGAA 155
TABLE 134 MERCK KGAA: BUSINESS OVERVIEW 155
FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT (2020) 155
11.1.3 PROMEGA CORPORATION 161
TABLE 135 PROMEGA CORPORATION: BUSINESS OVERVIEW 161
11.1.4 NEW ENGLAND BIOLABS 179
TABLE 136 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW 179
11.1.5 ILLUMINA, INC. 185
TABLE 137 ILLUMINA, INC.: BUSINESS OVERVIEW 185
FIGURE 31 ILLUMINA, INC.: COMPANY SNAPSHOT (2020) 186
11.1.6 TAKARA BIO, INC. 193
TABLE 138 TAKARA BIO, INC.: BUSINESS OVERVIEW 193
FIGURE 32 TAKARA BIO, INC.: COMPANY SNAPSHOT (2020) 193
11.1.7 QIAGEN N.V. 205
TABLE 139 QIAGEN N.V.: BUSINESS OVERVIEW 205
FIGURE 33 QIAGEN N.V.: COMPANY SNAPSHOT (2020) 205
11.1.8 AGILENT TECHNOLOGIES, INC. 224
TABLE 140 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW 224
FIGURE 34 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020) 225
11.1.9 F. HOFFMANN-LA ROCHE LTD. 229
TABLE 141 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 229
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 230
11.1.10 BIO BASIC INC. 233
TABLE 142 BIO BASIC INC.: BUSINESS OVERVIEW 233
11.1.11 JENA BIOSCIENCE GMBH 236
TABLE 143 JENA BIOSCIENCE GMBH: BUSINESS OVERVIEW 236
11.1.12 MOLECULAR BIOLOGY RESOURCES, INC. 250
TABLE 144 MOLECULAR BIOLOGY RESOURCES, INC.: BUSINESS OVERVIEW 250
11.1.13 BIO-RAD LABORATORIES, INC. 254
TABLE 145 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 254
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 254
*Business Overview, Products/Solutions Offered, Recent Developments, Right to Win might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 257
11.2.1 ZYMO RESEARCH CORPORATION 257
11.2.2 INTEGRATED DNA TECHNOLOGIES, INC. 258
11.2.3 LGC BIOSEARCH TECHNOLOGIES 259
11.2.4 NZYTECH, LDA. – GENES & ENZYMES 260
11.2.5 LUCIGEN CORPORATION 261
11.2.6 MOBITEC GMBH 262
11.2.7 GENEKAM BIOTECHNOLOGY AG 263
11.2.8 ALDEVRON 264
11.2.9 RANDOX LABORATORIES LTD. 264
11.2.10 ADS BIOTEC 265
11.2.11 HANGZHOU MATRIDX BIOTECHNOLOGY CO. LTD. 266
11.2.12 GOLDSITE DIAGNOSTICS INC. 266
12 APPENDIX 267
12.1 DISCUSSION GUIDE 267
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 269
12.3 AVAILABLE CUSTOMIZATIONS 271
12.4 RELATED REPORTS 271
12.5 AUTHOR DETAILS 272”

お問合せフォーム